載入...
Investigational Drug Treatments for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) and accounts for 10–20% of cases. Due to the lack of expression of several receptors, hormone therapy is largely ineffective for treatment purposes. Nevertheless, TNBC often responds very well to chemotherapy, which...
Na minha lista:
| 發表在: | J Pers Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8303312/ https://ncbi.nlm.nih.gov/pubmed/34357119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11070652 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|